This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Chunping Xu, Ph.D
Director of Chemistry R&D at TriLink BioTechnologies
Speaker

Profile

Chunping Xu is the Director of Chemistry R&D at TriLink Biotechnologies, where she oversees the development of novel CleanCap analogs for improved protein expression and process optimization for modified NTPs. In addition, she and her team are investigating how to increase mRNA stability with various chemical modifications. Leveraging expertise in nucleotide chemistry, Chunping and her team have created a library of over 70 novel cap analogs to identify next-generation CleanCap analogs. Before joining TriLink, Chunping had extensive experience in small molecule drug development and conjugation.

Agenda Sessions

  • Investigating Critical Quality Attributes of Cap2 mRNA Using Cap Analog Libraries

    12:05pm